Surface Oncology Inc (SURF)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE, MA 02139

Surface Oncology, Inc. operates as an immuno-oncology company. The Company develops therapies for the treatment of cancer. Surface Oncology serves clients in the State of Massachusetts.

Data as of 2021-04-11 08:05:01 -0400
Market Cap331.735 Million Shares Outstanding41.728 Million Avg 30-day Volume2.099 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-5.48 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.49013 52-week High/Low14.4 / 2.0 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SURF instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 90 62 45.16% 34 (2.04%) 23 (1.43%) 47.83%
13F shares: 20.172 Million 21.567 Million -6.47% 11.589 Million 14.172 Million -18.22%
% Ownership 50.5498 54.0443 -6.47% 29.0414 35.5127 -18.22%
New Positions: 41 25 64.0% 17 9 88.89%
Increased Positions 24 22 9.09% 6 9 -33.33%
Closed Positions 10 10 0.0% 6 7 -14.29%
Reduced Positions 18 8 125.0% 9 4 125.0%
Total Calls 141.98 Thousand 19.523 Thousand 627.24% 49.9 Thousand 19.5 Thousand 155.9%
Total Puts 241.35 Thousand 0 77.9 Thousand
PUT/CALL Ratio 1.7 0.0 1.56 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Surface Oncology Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding SURF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SURF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

1 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOATER JEFF

  • Director
 69,825 2021-04-01 4

FEES JESSICA SEE REMARKS

  • Officer
 68,000 2021-03-01 5

PALOMBELLA VITO J. CHIEF SCIENTIFIC OFFICER

  • Officer
 82,000 2021-03-01 1

NOGELO LIISA I CHIEF LEGAL OFFICER

  • Officer
 82,000 2021-03-01 1

ROSS ROBERT W. CHIEF MEDICAL OFFICER

  • Officer
 88,000 2021-02-16 8

GRAYZEL DAVID S.

  • Director
 2,945,453 2020-12-17 3

ATLAS VENTURE FUND IX, L.P.

ATLAS VENTURE ASSOCIATES IX, L.P.

ATLAS VENTURE ASSOCIATES IX, LLC

  • 10% Owner
 2,945,453 2020-12-17 2

ECOR1 CAPITAL, LLC

  • 10% Owner
 4,701,081 2020-09-01 2

LYNCH DANIEL

  • Director
 0 2020-06-10 1

MCDONOUGH GEOFF

  • Director
 0 2020-06-10 1

STELZER LAURIE

  • Director
 0 2020-06-10 1

SHANAFELT ARMEN

  • Director
  • 10% Owner
 0 2020-06-10 1

SIGAL CHARLES ELLIOTT

  • Director
 0 2020-06-10 1

IBRAHIM RAMY

  • Director
 0 2020-06-10 1

NEW ENTERPRISE ASSOCIATES 14, L.P.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

BASKETT FOREST

FLORENCE ANTHONY A. JR.

KERINS PATRICK J

SANDELL SCOTT D

SONSINI PETER W.

  • 10% Owner
 2,892,877 2020-05-20 1

DWYER WENDY CHIEF BUSINESS OFFICER

  • Officer
 85,000 2020-02-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GOATER JEFF - Director

2021-04-02 20:25:22 -0400 2021-04-01 A 15,000 a 15,000 direct

GOATER JEFF - Director

2021-04-02 20:25:22 -0400 2021-04-01 A 4,425 a 4,425 direct

GOATER JEFF - Director

2021-04-02 20:25:22 -0400 2021-04-01 A 15,000 a 15,000 direct

GOATER JEFF - Director

2021-04-02 20:25:22 -0400 2021-04-01 A 35,400 a 35,400 direct

NOGELO LIISA I - Officer CHIEF LEGAL OFFICER

2021-03-03 20:17:22 -0500 2021-03-01 A 82,000 a 82,000 direct

FEES JESSICA - Officer SEE REMARKS

2021-03-03 20:16:21 -0500 2021-03-01 A 68,000 a 68,000 direct

PALOMBELLA VITO J. - Officer CHIEF SCIENTIFIC OFFICER

2021-03-03 20:17:53 -0500 2021-03-01 A 82,000 a 82,000 direct

ROSS ROBERT W. - Officer CHIEF MEDICAL OFFICER

2021-02-18 20:00:19 -0500 2021-02-16 S 1,000 $11.35 d 88,000 direct yes -4.4211 -10.7368 -13.0526 0.5263 22 -23.6842 28

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SURFACE ONCOLOGY INC SURF 2021-04-14 22:15:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 21:45:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 21:15:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 20:45:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 20:15:04 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 19:45:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 19:15:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 18:45:02 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 18:15:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 17:45:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 17:15:03 UTC -0.4319 0.4919 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 16:45:03 UTC -0.4336 0.4936 1100000
SURFACE ONCOLOGY INC SURF 2021-04-14 16:15:03 UTC -0.4336 0.4936 1300000
SURFACE ONCOLOGY INC SURF 2021-04-14 15:45:03 UTC -0.4336 0.4936 1300000
SURFACE ONCOLOGY INC SURF 2021-04-14 15:15:03 UTC -0.4336 0.4936 1300000
SURFACE ONCOLOGY INC SURF 2021-04-14 14:45:02 UTC -0.4286 0.4886 1400000
SURFACE ONCOLOGY INC SURF 2021-04-14 14:15:03 UTC -0.4286 0.4886 1300000
SURFACE ONCOLOGY INC SURF 2021-04-14 13:45:03 UTC -0.4286 0.4886 1300000
SURFACE ONCOLOGY INC SURF 2021-04-14 13:15:03 UTC -0.4286 0.4886 1300000
SURFACE ONCOLOGY INC SURF 2021-04-14 12:45:03 UTC -0.4286 0.4886 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments